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eLife’s transparent reporting form 
 
We encourage authors to provide detailed information within their submission to facilitate 
the interpretation and replication of experiments. Authors can upload supporting 
documentation to indicate the use of appropriate reporting guidelines for health-related 
research (see EQUATOR Network), life science research (see the BioSharing Information 
Resource), or the ARRIVE guidelines for reporting work involving animal research. Where 
applicable, authors should refer to any relevant reporting standards documents in this form. 
 
If you have any questions, please consult our Journal Policies and/or contact us: 
editorial@elifesciences.org. 
 
Sample-size estimation 
• You should state whether an appropriate sample size was computed when the 
study was being designed  
• You should state the statistical method of sample size computation and any 
required assumptions 
• If no explicit power analysis was used, you should describe how you decided what 
sample (replicate) size (number) to use 
 
Please outline where this information can be found within the submission (e.g., sections or 
figure legends), or explain why this information doesn’t apply to your submission: 
 
Replicates 
• You should report how often each experiment was performed 
• You should include a definition of biological versus technical replication 
• The data obtained should be provided and sufficient information should be 
provided to indicate the number of independent biological and/or technical 
replicates 
• If you encountered any outliers, you should describe how these were handled 
• Criteria for exclusion/inclusion of data should be clearly stated 
• High-throughput sequence data should be uploaded before submission, with a 
private link for reviewers provided (these are available from both GEO and 
ArrayExpress) 
 
Please outline where this information can be found within the submission (e.g., sections or 
figure legends), or explain why this information doesn’t apply to your submission: 
 
  
There is no applicable sample-size estimation in this study.  
 
For ELISA binding assays and neutralization experiments, data from one 
experiment representative of two independent experiments is shown in the 
paper.  
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Statistical reporting 
• Statistical analysis methods should be described and justified 
• Raw data should be presented in figures whenever informative to do so (typically 
when N per group is less than 10) 
• For each experiment, you should identify the statistical tests used, exact values of 
N, definitions of center, methods of multiple test correction, and dispersion and 
precision measures (e.g., mean, median, SD, SEM, confidence intervals; and, for the 
major substantive results, a measure of effect size (e.g., Pearson's r, Cohen's d) 
• Report exact p-values wherever possible alongside the summary statistics and 95% 
confidence intervals. These should be reported for all key questions and not only 
when the p-value is less than 0.05. 
 
Please outline where this information can be found within the submission (e.g., sections or 
figure legends), or explain why this information doesn’t apply to your submission: 
 
(For large datasets, or papers with a very large number of statistical tests, you may upload a 
single table file with tests, Ns, etc., with reference to sections in the manuscript.) 
 
Group allocation 
• Indicate how samples were allocated into experimental groups (in the case of 
clinical studies, please specify allocation to treatment method); if randomization 
was used, please also state if restricted randomization was applied 
• Indicate if masking was used during group allocation, data collection and/or data 
analysis 
 
Please outline where this information can be found within the submission (e.g., sections or 
figure legends), or explain why this information doesn’t apply to your submission: 
 
Additional data files (“source data”) 
• We encourage you to upload relevant additional data files, such as numerical data 
that are represented as a graph in a figure, or as a summary table 
• Where provided, these should be in the most useful format, and they can be 
uploaded as “Source data” files linked to a main figure or table 
• Include model definition files including the full list of parameters used 
• Include code used for data analysis (e.g., R, MatLab) 
• Avoid stating that data files are “available upon request” 
 
Please indicate the figures or tables for which source data files have been provided: 
For ELISA binding assay and neutralization experiment, means ± s.d. of duplicates are 
reported. There is no applicable p-value in this study. For reported X-ray crystal 
structure statistics are reported in Figure 4-figure supplement 1. 
There is no applicable group allocation in this study.  
 
The structure will be uploaded to PDB.  The statistics of crystal structure are listed in 
Figure 4-figure supplement 1. 
 
The data from ELISA binding and neutralization assays are provided in Figure 2-figure 
supplement 1 and Figure 2-figure supplement 2. 
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